Fire at 00:19, 5 November 2023

2023-11-05T00:19:07Z

Fire at 00:00, 5 November 2023

2023-11-05T00:00:02Z

← Older revision		Revision as of 09:00, 5 November 2023
Line 1:		Line 1:
	{{Navbox		{{Navbox
	\| name = Sympatholytic antihypertensives		\| name = Sympatholytic antihypertensives/ja
	\| title = [[Sympatholytic]] ~~(and closely related)~~ [[antihypertensive]]s ([[ATC code C02\|C02]])		\| title = [[Sympatholytic/ja\|交感神経溶解薬]]（および密接に関連した）[[antihypertensive/ja\|抗高血圧薬]] ([[ATC code C02/ja\|C02]])
	\| state = {{{state<includeonly>\|autocollapse</includeonly>}}}		\| state = {{{state<includeonly>\|autocollapse</includeonly>}}}
	\| listclass = hlist		\| listclass = hlist

Fire: Created page with "{{Navbox | name = Sympatholytic antihypertensives | title = Sympatholytic (and closely related) antihypertensives (C02) | state = {{{state|autocollapse}}} | listclass = hlist | group1 = Sympatholytics
(antagonize α-adrenergic
vasoconstriction) | list1 = {{Navbox|child | group1 = Central | list1 = {{Navbox|child | group1 = Alpha-adrenergic..."

2023-11-04T23:58:28Z

Created page with "{{Navbox | name = Sympatholytic antihypertensives | title = Sympatholytic (and closely related) antihypertensives (C02) | state = {{{state<includeonly>|autocollapse</includeonly>}}} | listclass = hlist | group1 = Sympatholytics (antagonize α-adrenergic vasoconstriction) | list1 = {{Navbox|child | group1 = Central | list1 = {{Navbox|child | group1 = Alpha-adrenergic..."

New page

{{Navbox
| name = Sympatholytic antihypertensives
| title = [[Sympatholytic]] (and closely related) [[antihypertensive]]s ([[ATC code C02|C02]])
| state = {{{state<includeonly>|autocollapse</includeonly>}}}
| listclass = hlist

| group1 = [[Sympatholytic]]s (antagonize [[Adrenergic receptor#.CE.B1 receptors|α-adrenergic]] [[vasoconstriction]])
| list1 = {{Navbox|child

| group1 = Central
| list1 = {{Navbox|child

| group1 = [[Alpha-adrenergic agonist#.CE.B12 agonists|α2-Adrenergic receptor agonist]]s
| list1 =
* [[Clonidine]]
* [[Guanabenz]]
* [[Guanfacine]]
* [[Guanoxabenz]]
* [[Methyldopa]]#
* [[Tiamenidine]]‡

| group2 = [[Adrenergic release inhibitor]]s
| list2 =
* [[Bethanidine]]
* [[Bretylium]]
* [[Debrisoquine]]
* [[Guanadrel]]
* [[Guanazodine]]
* [[Guancydine]]
* [[Guanethidine]]
* [[Guanoclor]]
* [[Guanoxan]]

| group3 = [[Imidazoline receptor]] agonists
| list3 =
* [[Moxonidine]]
* [[Rilmenidine]]
* [[Tolonidine]]

| group4 = [[Ganglionic blocker|Ganglion-blocking]]/[[nicotinic antagonist]]s
| list4 =
* [[Hexamethonium]]‡
* [[Mecamylamine]]
* [[Pentolinium]]
* [[Trimetaphan camsilate|Trimethaphan]]

}}

| group2 = Peripheral
| list2 = {{Navbox|child

| group1 = Indirect
| list1 = {{Navbox|child

| group1 = [[Monoamine oxidase inhibitor]]s
| list1 =
* [[Pargyline]]‡

| group2 = [[VMAT inhibitor]]s
| list2 =
* [[Bietaserpine]]
* [[Deserpidine]]
* [[Methoserpidine]]
* [[Reserpine]]
* [[Syrosingopine]]

| group3 = [[Tyrosine hydroxylase inhibitor]]s
| list3 =
* [[Metirosine]]

}}

| group2 = Direct
| list2 = {{Navbox|child

| group1 = [[Alpha-1 blocker|α1-Adrenergic receptor blocker]]s
| list1 =
* [[Doxazosin]]
* [[Ketanserin]]
* [[Indoramin]]
* [[Prazosin]]
* [[Trimazosin]]
* [[Urapidil]]

| group2 = [[Alpha blocker|Non-selective α-adrenergic receptor blockers]]
| list2 =
* [[Phentolamine]]

}}
}}
}}

| group2 = Other [[Receptor antagonist|antagonist]]s
| list2 = {{Navbox|child

| group1 = [[Serotonin receptor antagonist]]s
| list1 =
* [[Ketanserin]]
* [[Lidanserin]]

| group2 = [[Endothelin receptor antagonist]]s (for {{Abbrlink|PH|Pulmonary hypertension}})
| list2 =
* ''dual'' ([[Bosentan]], [[Macitentan]])
* ''selective'' ([[Ambrisentan]], [[Sitaxentan]])

}}

| belowstyle = background: transparent; padding: 0px;
| below = {{PharmNavFootnote}}

}}<noinclude>
{{collapsible option}}
[[Category:Drug templates by ATC]]
</noinclude>

Template:Endothelial antihypertensives/ja - Revision history

Fire at 00:19, 5 November 2023

Fire at 00:00, 5 November 2023